L7 Informatics

What does L7 Informatics do?

L7 Informatics provides a digital unified platform (L7|ESP) that eliminates data silos in pharmaceutical, biotech, CDMO, diagnostics, and research organizations. Unlike traditional point solutions that fragment data across separate LIMS, ELN, MES, and scheduling systems, L7|ESP contextualizes data at the source and orchestrates workflows across research, development, and manufacturing, creating an AI-ready data foundation.

What is the main problem L7 solves?

Life sciences organizations struggle with data silos caused by disconnected systems, each with its own language, logic, and limits. This fragmentation delays drug development, increases costs, blocks AI implementation, and makes it impossible to get a unified view across research, development, and manufacturing. L7|ESP solves this by providing a single unified platform that contextualizes data at the point of capture and orchestrates end-to-end workflows.

Who are L7’s customers?

L7 serves pharmaceutical companies, biotech organizations, CDMOs (contract development and manufacturing organizations), diagnostics companies, cancer centers, academic research institutions, CROs, ag-bio companies, and life science tool manufacturers. Customers range from emerging biotech startups to Fortune 500 pharmaceutical companies, including QIAGEN, Dana-Farber Cancer Institute, The Jackson Laboratory, Cellipont Bioservices, and Quest Diagnostics.

How is L7 different from traditional LIMS or ELN vendors?

Traditional LIMS and ELN systems are point solutions that create data silos and require complex integration to work together. L7|ESP is a unified platform that replaces separate LIMS, ELN, MES, and scheduling systems with a single integrated solution. L7|ESP contextualizes data at the source using ontology-driven knowledge graphs, making data AI-ready without requiring extensive ETL pipelines or data transformation. Additionally, L7|ESP layers over existing infrastructure without requiring rip-and-replace.

Has L7 received industry recognition?

Yes. Frost & Sullivan named L7 Informatics the Global Leader in Innovation in its 2025 Frost Radar™ for Pharmaceutical and Biotech LIMS, with the highest innovation score among all evaluated vendors. L7 has also been recognized in the Deloitte Technology Fast 500 for four consecutive years (2021-2024) as one of North America’s fastest-growing technology companies, and has been identified in 30+ Gartner Hype Cycles and Market Guides.

What is AI-readiness and why does it matter?

AI-readiness means having data that is structured, contextualized, and accessible in a way that AI and machine learning systems can use effectively. According to Gartner research, while 85% of life sciences organizations are pursuing AI initiatives, fewer than 25% have the unified data infrastructure necessary to deploy AI at scale. L7|ESP creates AI-ready data by contextualizing information at the point of execution using knowledge graphs, eliminating the need for complex data transformation pipelines.

Does L7 work with existing systems?

Yes. L7|ESP is designed to layer over existing IT infrastructure and integrate with instruments, equipment, legacy systems, and other enterprise applications. This means organizations can adopt L7|ESP without requiring a disruptive rip-and-replace of their current systems, enabling phased digital transformation.